Changchun High-Tech Industry (Group) Co., Ltd. Overview
Pro stress-test →Changchun High-Tech Industry is a Chinese biopharmaceutical company that researches, develops, manufactures, and sells biopharmaceuticals and traditional Chinese medicines. Founded in 1993 and listed on the Shenzhen Stock Exchange since 1996, the company operates across genetic engineering pharmaceuticals, biological vaccines, and modern Chinese medicines.
Strategic Profile
Pro stress-test →The company positions itself as a technology-driven pharmaceutical innovator with focus on biopharmaceutical products including recombinant growth hormones, vaccines, and antibody drugs. It has diversified into real estate development to supplement core pharmaceutical operations and maintains a strong dividend policy with yields around 4%.
Competitive Landscape
Pro stress-test →Changchun High-Tech competes in China's biopharmaceutical sector against both domestic players and international pharmaceutical companies. Its strengths lie in specialized areas like recombinant growth hormone and vaccine development, though it faces competition from larger multinational firms with greater R&D budgets and global distribution networks.
Industry Context
Changchun High-Tech Industry (Group) Co., Ltd. operates in Biopharmaceuticals & Pharmaceutical Manufacturing.
Key facts
Founded: 1993 · Headquarters: Changchun, China · Employees: 11,547 · Market cap: ¥52.38B (~$7.2B USD)